03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Yondelis* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Janssen |
Responsible Party | Janssen Pharmaceutica NV |
Origin | Belgium |
Manufacturer | Baxter Oncology GmbH |
Origin | Germany |
ATC | L01CX01 |
Revision Date | 26/10/2012 |
Yondelis* :
Yondelis* :
Yondelis* :
Yondelis* :
Yondelis* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Yondelis* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abdominal pain upper | Common |
Alopecia | Very Common |
ALT increased | Very Common |
Anaemia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Common |
AST increased | Very Common |
Asthenia | Very Common |
Back pain | Common |
Bilirubin conjugated increased | Not known |
Blood albumin decreased | Very Common |
Blood alkaline phosphatase increased | Very Common |
Blood creatine phosphokinase increased | Very Common |
Blood creatinine increased | Very Common |
Bone marrow failure | Not known |
Catheter site related reaction | Not known |
Constipation | Very Common |
Cough | Common |
Decreased appetite | Very Common |
Dehydration | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Flushing | Common |
Gamma-GT increased | Very Common |
Granulocytopenia | Not known |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Very Common |
Headache | Very Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Rare |
Hepatotoxicity (liver toxicity) | Not known |
Hyperbilirubinaemia | Very Common |
Hypersensitivity | Not known |
Hypokalaemia | Common |
Hypotension | Common |
Infection | Common |
Injection site reaction | Common |
Insomnia | Common |
Left ventricular dysfunction | Not known |
Leucopenia (Leukopenia) | Very Common |
Mucosal inflammation | Very Common |
Musculoskeletal pain | Not known |
Myalgia | Common |
Nausea | Very Common |
Neutropenia | Very Common |
Neutropenic infection | Not known |
Neutropenic sepsis | Not known |
Oedema | Common |
Oedema peripheral | Common |
Pancytopenia | Not known |
Paraesthesia (paresthesia) | Common |
Peripheral sensory neuropathy | Common |
Pulmonary embolism | Not known |
Pulmonary oedema | Not known |
Pyrexia | Very Common |
Rhabdomyolysis | Not known |
Septic shock | Uncommon |
Skin hyperpigmentation | Common |
Skin rash | Common |
Soft tissue necrosis | Not known |
Stomatitis | Very Common |
Syncope | Not known |
Thrombocytopenia (Thrombopenia) | Very Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Common |
Yondelis* :
NB : Products With Same Indication |
Different Units By MoH Code
Yondelis* MoH 5956 :
Form | Powder for concentrate for solution for infusion |
Packaging | Bottle (Glass) |
Package Size | Box of 1 |
Strength | 1mg |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 219280/09 |
Submission date | 01/01/2009 |
Registration Year | 2010 |
Archived Date | 03/04/2023 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 1 | |
● Public Price: | 13090 QAR | ( 321,464,220.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 13090 QAR | ( 321,464,220.00 LBP ) |
● Pharmacy Price: | 10752.50656558 QAR | ( 264060056.23751 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 1 | |
● Public Price: | 1378.25 OMR | ( 318,009,135.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1378,25 OMR | ( 317,951,452.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1 | |
● Public Price: | 12232 AED | ( 295,537,352.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 12232 AED | ( 295,537,352.00 LBP ) |
● Pharmacy Price: | 10419.9 AED | ( 251755203.9 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 1 Glass Vial (Powder) | |
● Public Price: | 12232 AED | ( 295,537,352.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 12232 AED | ( 295,537,352.00 LBP ) |
● Pharmacy Price: | 10419.86 AED | ( 251754237.46 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 1 | |
● Public Price: | 2970.05 EUR | ( 287,726,563.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2970,05 EUR | ( 287,721,720.00 LBP ) |
● Exfactory Price: | 1799.59 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 1 | |
● Public Price: | 1163.45 BHD | ( 276,591,622.30 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1163,45 BHD | ( 276,484,642.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 1 | |
● Public Price: | 19987.2 DKK | ( 259,353,907.20 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 19987,2 DKK | ( 259,351,312.00 LBP ) |
● Pharmacy Price: | 14855.3 DKK | ( 192762372.8 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Germany | |
● Package Size: | 1 | |
● Public Price: | 2570.12 EUR | ( 248,982,945.12 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2570,12 EUR | ( 248,971,320.00 LBP ) |
● Pricing Date: | 20/10/2020 | |
● Type: | Medicine paralel import (PIP) |
● Country: | Finland | |
● Package Size: | 1 | |
● Public Price: | 2520.82 EUR | ( 244,206,958.32 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2520,82 EUR | ( 244,127,520.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 1 | |
● Public Price: | 359325 ISK | ( 231,764,625.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 359325 ISK | ( 231,764,625.00 LBP ) |
● Pharmacy Price: | 283804 ISK | ( 183053580 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 1 | |
● Public Price: | 2239.95 CHF | ( 231,655,629.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2239,95 CHF | ( 231,557,380.00 LBP ) |
● Exfactory Price: | 1986.29 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 25ml | |
● Public Price: | 9479.6 SAR | ( 224,097,744.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 9479,6 SAR | ( 224,083,560.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1 | |
● Public Price: | 2131.91 EUR | ( 206,530,913.16 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2131,91 EUR | ( 206,442,756.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 1 | |
● Public Price: | 2003.42 EUR | ( 194,083,315.92 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2003,42 EUR | ( 194,042,628.00 LBP ) |
● Pharmacy Price: | 1996.42 EUR | ( 193405183.92 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 1 | |
● Public Price: | 1792.46 EUR | ( 173,646,354.96 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1792,46 EUR | ( 173,601,792.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 1 | |
● Public Price: | 1743 EUR | ( 168,854,868.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1743 EUR | ( 168,854,868.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 1 | |
● Public Price: | 20286.5 NOK | ( 164,401,796.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 20286,5 NOK | ( 164,397,744.00 LBP ) |
● Pharmacy Price: | 15805.08 NOK | ( 128084368.32 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1 | |
● Public Price: | 1366 GBP | ( 155,244,534.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1366 GBP | ( 155,244,534.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 1 | |
● Public Price: | 1486.8 EUR | ( 144,035,236.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1486,8 EUR | ( 143,957,736.00 LBP ) |
● Exfactory Price: | 1325.58 EUR | |
● Pharmacy Price: | 1345.46 EUR | ( 130342782.96 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 1 | |
● Public Price: | 807.389 EUR | ( 78,216,616.76 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 807,389 EUR | ( 78,178,932.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 1 | |
● Public Price: | 10008.75 TRY | ( 26,823,450.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 10008,75 TRY | ( 26,821,440.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Portugal |
● Package Size: | 1 |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
● Country: | Jordan |
● Package Size: | 1 |
● Reference: | JFDA |
● Pricing Date: | 04/11/2020 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File